Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1712

1.

Characterization of the microbiota in long- and short-term natural indigo fermentation.

Tu Z, de Fátima Silva Lopes H, Igarashi K, Yumoto I.

J Ind Microbiol Biotechnol. 2019 Aug 20. doi: 10.1007/s10295-019-02223-0. [Epub ahead of print]

PMID:
31432338
2.

A new technique for motion encoding gradient-less MR elastography of the psoas major muscle: A gradient-echo type multi-echo sequence.

Numano T, Habe T, Ito D, Onishi T, Takamoto K, Mizuhara K, Nishijo H, Igarashi K, Ueki T.

Magn Reson Imaging. 2019 Aug 16. pii: S0730-725X(19)30007-4. doi: 10.1016/j.mri.2019.08.006. [Epub ahead of print]

PMID:
31425804
3.

Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model.

Higuchi T, Sugisawa N, Miyake K, Oshiro H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Chawla SP, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Anticancer Res. 2019 Aug;39(8):4079-4084. doi: 10.21873/anticanres.13565.

PMID:
31366491
4.

Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.

Ogura I, Kobayashi E, Nakahara K, Igarashi K, Haga-Tsujimura M, Toshima H.

Ann Nucl Med. 2019 Jul 24. doi: 10.1007/s12149-019-01390-5. [Epub ahead of print]

PMID:
31342316
5.

Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.

Nishizawa N, Harada H, Kumamoto Y, Kaizu T, Katoh H, Tajima H, Ushiku H, Yokoi K, Igarashi K, Fujiyama Y, Okuwaki K, Iwai T, Watanabe M, Yamashita K.

Cancer Sci. 2019 Jul 19. doi: 10.1111/cas.14134. [Epub ahead of print]

6.

Lipid peroxidation increases hydrogen peroxide permeability leading to cell death in cancer cell lines that lack mtDNA.

Tomita K, Takashi Y, Ouchi Y, Kuwahara Y, Igarashi K, Nagasawa T, Nabika H, Kurimasa A, Fukumoto M, Nishitani Y, Sato T.

Cancer Sci. 2019 Jul 17. doi: 10.1111/cas.14132. [Epub ahead of print]

7.

Polymeric Micelles Loading Proteins through Concurrent Ion Complexation and pH-Cleavable Covalent Bonding for In Vivo Delivery.

Tao A, Huang GL, Igarashi K, Hong T, Liao S, Stellacci F, Matsumoto Y, Yamasoba T, Kataoka K, Cabral H.

Macromol Biosci. 2019 Jul 16:e1900161. doi: 10.1002/mabi.201900161. [Epub ahead of print]

PMID:
31310454
8.

The Combination of Olaratumab with Doxorubicin and Cisplatinum Regresses a Chemotherapy-Resistant Osteosarcoma in a Patient-Derived Orthotopic Xenograft Mouse Model.

Higuchi T, Sugisawa N, Miyake K, Oshiro H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Transl Oncol. 2019 Sep;12(9):1257-1263. doi: 10.1016/j.tranon.2019.06.002. Epub 2019 Jul 9.

9.

The sub-classification of type B2 vessels according to the magnifying endoscopic classification of the Japan Esophageal Society.

Tanaka I, Hirasawa D, Saito H, Matsuda T, Nakahori M, Maeda Y, Okuzono T, Suzuki K, Igarashi K, Nawata Y, Ito S, Unno S, Chonan A.

Dig Endosc. 2019 Jun 8. doi: 10.1111/den.13459. [Epub ahead of print]

PMID:
31177563
10.

Inhibition of dendritic spine extension through acrolein conjugation with α-, β-tubulin proteins.

Uemura T, Suzuki T, Ko K, Watanabe K, Dohmae N, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K.

Int J Biochem Cell Biol. 2019 Aug;113:58-66. doi: 10.1016/j.biocel.2019.05.016. Epub 2019 May 28.

PMID:
31150838
11.

Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.

Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H, Narita M.

Brain. 2019 Jun 1;142(6):1675-1689. doi: 10.1093/brain/awz084.

PMID:
31135049
12.

Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Higuchi T, Singh SR, Tsuchiya H, Hoffman RM.

Tissue Cell. 2019 Jun;58:107-111. doi: 10.1016/j.tice.2019.04.010. Epub 2019 May 3.

PMID:
31133237
13.

Erratum for Shen et al., "Identification of a Novel Enhancer/Chromatin Opening Element Associated with High-Level γ-Globin Gene Expression".

Shen Y, Bassett MA, Gurumurthy A, Nar R, Knudson IJ, Guy CR, Perez A, Mellen RW, Ikeda M, Hossain MA, Huang S, Igarashi K, Bungert J.

Mol Cell Biol. 2019 May 14;39(11). pii: e00168-19. doi: 10.1128/MCB.00168-19. Print 2019 Jun 1. No abstract available.

14.

Synthetic glycopeptides reveal specific binding pattern and conformational change at O-mannosylated position of α-dystroglycan by POMGnT1 catalyzed GlcNAc modification.

Hinou H, Kikuchi S, Ochi R, Igarashi K, Takada W, Nishimura SI.

Bioorg Med Chem. 2019 Jul 1;27(13):2822-2831. doi: 10.1016/j.bmc.2019.05.008. Epub 2019 May 6.

PMID:
31079966
15.

Strategy towards tailored donor tissue-specific pancreatic islet isolation.

Miyazaki Y, Murayama K, Fathi I, Imura T, Yamagata Y, Watanabe K, Maeda H, Inagaki A, Igarashi Y, Miyagi S, Shima H, Igarashi K, Kamei T, Unno M, Goto M.

PLoS One. 2019 May 10;14(5):e0216136. doi: 10.1371/journal.pone.0216136. eCollection 2019.

16.

Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin.

Kojima K, Minatani N, Ushiku H, Ishii S, Tanaka T, Yokoi K, Nishizawa N, Ooizumi Y, Igarashi K, Hosoda K, Moriya H, Mieno H, Watanabe M, Yamashita K.

Oncotarget. 2019 Mar 29;10(25):2423-2434. doi: 10.18632/oncotarget.26814. eCollection 2019 Mar 29.

17.

Full Laparoscopic Anatomical Segment 8 Resection for Hepatocellular Carcinoma Using the Glissonian Approach with Indocyanine Green Dye Fluorescence.

Berardi G, Wakabayashi G, Igarashi K, Ozaki T, Toyota N, Tsuchiya A, Nishikawa K.

Ann Surg Oncol. 2019 Aug;26(8):2577-2578. doi: 10.1245/s10434-019-07422-8. Epub 2019 May 7.

PMID:
31065966
18.

Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.

Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Murakami T, Unno M, Hoffman RM.

Cells. 2019 May 2;8(5). pii: E410. doi: 10.3390/cells8050410. Review.

19.

TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages.

Sudan K, Vijayan V, Madyaningrana K, Gueler F, Igarashi K, Foresti R, Motterlini R, Immenschuh S.

Free Radic Biol Med. 2019 Jun;137:131-142. doi: 10.1016/j.freeradbiomed.2019.04.024. Epub 2019 Apr 24.

20.

PEG-OligoRNA Hybridization of mRNA for Developing Sterically Stable Lipid Nanoparticles toward In Vivo Administration.

Kurimoto S, Yoshinaga N, Igarashi K, Matsumoto Y, Cabral H, Uchida S.

Molecules. 2019 Apr 3;24(7). pii: E1303. doi: 10.3390/molecules24071303.

21.

Laparoscopic liver resection-education and training.

Berardi G, Igarashi K, Wakabayashi G.

Transl Gastroenterol Hepatol. 2019 Feb 18;4:11. doi: 10.21037/tgh.2019.01.10. eCollection 2019. No abstract available.

22.

Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model.

Higuchi T, Miyake K, Oshiro H, Sugisawa N, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Chawla SP, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Biochem Biophys Res Commun. 2019 May 28;513(2):326-331. doi: 10.1016/j.bbrc.2019.03.191. Epub 2019 Apr 5.

PMID:
30955860
23.

Successful treatment of pathologic femoral shaft fracture associated with large arteriovenous malformations using a 3-dimensional external fixator and teriparatide: a case report.

Takeuchi A, Matsubara H, Yamamoto N, Hayashi K, Miwa S, Igarashi K, Inatani H, Tsuchiya H.

BMC Surg. 2019 Apr 5;19(1):35. doi: 10.1186/s12893-019-0498-4.

24.

Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.

Miyake K, Murata T, Murakami T, Zhao M, Kiyuna T, Kawaguchi K, Igarashi K, Miyake M, Lwin TM, Hozumi C, Komatsu S, Kikuchi T, Bouvet M, Shimoya K, Singh SR, Endo I, Hoffman RM.

Arch Gynecol Obstet. 2019 Jun;299(6):1683-1690. doi: 10.1007/s00404-019-05147-3. Epub 2019 Apr 5.

PMID:
30953192
25.

Determining Patient Satisfaction and Treatment Desires in Patients With Musculoskeletal Sarcoma of the Knee After Joint-preservation Surgery Using a Questionnaire Survey.

Abe K, Yamamoto N, Hayashi K, Takeuchi A, Kato S, Miwa S, Igarashi K, Inatani H, Aoki YU, Higuchi T, Taniguchi Y, Tsuchiya H.

Anticancer Res. 2019 Apr;39(4):1965-1969. doi: 10.21873/anticanres.13307.

PMID:
30952740
26.

Satisfaction After Joint-preservation Surgery in Patients With Musculoskeletal Knee Sarcoma Based on Various Scores.

Abe K, Yamamoto N, Hayashi K, Takeuchi A, Kato S, Miwa S, Igarashi K, Inatani H, Aoki YU, Higuchi T, Taniguchi Y, Tsuchiya H.

Anticancer Res. 2019 Apr;39(4):1959-1964. doi: 10.21873/anticanres.13306.

PMID:
30952739
27.

Biophysical characterization of heme binding to the intrinsically disordered region of Bach1.

Segawa K, Watanabe-Matsui M, Tsuda K, Matsui T, Shirouzu M, Igarashi K, Murayama K.

Eur Biophys J. 2019 May;48(4):361-369. doi: 10.1007/s00249-019-01364-5. Epub 2019 Apr 1.

PMID:
30937482
28.

Performance of a repair service set for the retrieval of fractured abutment screws: a pilot in vitro study.

Igarashi K, Afrashtehfar KI, Schimmel M, Gazzaz A, Brägger U.

Int J Oral Maxillofac Implants. 2019 May/June;34(3):567–573. doi: 10.11607/jomi.7106. Epub 2019 Apr 1.

PMID:
30934039
29.

Bridging the Micro-Macro Gap between Single-Molecular Behavior and Bulk Hydrolysis Properties of Cellulase.

Ezaki T, Nishinari K, Samejima M, Igarashi K.

Phys Rev Lett. 2019 Mar 8;122(9):098102. doi: 10.1103/PhysRevLett.122.098102.

PMID:
30932525
30.

CiApex1 has AP endonuclease activity and abrogated AP site repair disrupts early embryonic development in Ciona intestinalis.

Igarashi K, Funakoshi M, Kato S, Moriwaki T, Kato Y, Zhang-Akiyama QM.

Genes Genet Syst. 2019 Apr 27;94(2):81-93. doi: 10.1266/ggs.18-00043. Epub 2019 Apr 1.

31.

The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model.

Higuchi T, Miyake K, Sugisawa N, Oshiro H, Zhang Z, Razmjooei S, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1075-1082. doi: 10.1007/s00280-019-03824-3. Epub 2019 Mar 30.

PMID:
30929053
32.

[Influence of Vibration Waveform on MR Elastography].

Tanaka M, Numano T, Habe T, Ito D, Maeno T, Ueki T, Igarashi K, Mizuhara K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(3):239-246. doi: 10.6009/jjrt.2019_JSRT_75.3.239. Japanese.

33.

Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model.

Higuchi T, Miyake K, Sugisawa N, Oshiro H, Zhang Z, Razmjooei S, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Lett. 2019 Jun 1;451:122-127. doi: 10.1016/j.canlet.2019.03.003. Epub 2019 Mar 10.

PMID:
30867142
34.

Assessing acrolein for determination of the severity of brain stroke, dementia, renal failure, and Sjögren's syndrome.

Igarashi K, Uemura T, Kashiwagi K.

Amino Acids. 2019 Mar 12. doi: 10.1007/s00726-019-02700-x. [Epub ahead of print] Review.

PMID:
30863888
35.

Functional Heme Binding to the Intrinsically Disordered C-Terminal Region of Bach1, a Transcriptional Repressor.

Segawa K, Watanabe-Matsui M, Matsui T, Igarashi K, Murayama K.

Tohoku J Exp Med. 2019 Mar;247(3):153-159. doi: 10.1620/tjem.247.153.

36.

Draft Genome Sequence of Thermosipho globiformans Strain MN14.

Igarashi K.

Microbiol Resour Announc. 2019 Feb 28;8(9). pii: e01728-18. doi: 10.1128/MRA.01728-18. eCollection 2019 Feb.

37.

Serum autotaxin levels are associated with Graves' disease.

Nojiri T, Kurano M, Araki O, Nakawatari K, Nishikawa M, Shimamoto S, Igarashi K, Kano K, Aoki J, Kihara S, Murakami M, Yatomi Y.

Endocr J. 2019 May 28;66(5):409-422. doi: 10.1507/endocrj.EJ18-0451. Epub 2019 Mar 27.

38.

Osimertinib Regresses an EGFR-Mutant Cisplatinum- Resistant Lung Adenocarcinoma Growing in the Brain in Nude Mice.

Higuchi T, Oshiro H, Zhang Z, Miyake K, Sugisawa N, Katsuya Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Zhao M, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Transl Oncol. 2019 Apr;12(4):640-645. doi: 10.1016/j.tranon.2019.01.007. Epub 2019 Feb 23.

39.

A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma.

Zhang Z, Hu K, Kiyuna T, Miyake K, Kawaguchi K, Igarashi K, Nelson SD, Li Y, Singh SR, Hoffman RM.

Pharmacol Res. 2019 Apr;142:169-175. doi: 10.1016/j.phrs.2019.02.021. Epub 2019 Feb 23.

PMID:
30807865
40.

Hemoglobin(βC93A)-Albumin Cluster: Mutation of Cysteine-β93 to Alanine Allows Moderate Reduction of O2 Affinity by Inositol Hexaphosphate.

Morita Y, Igarashi K, Funaki R, Komatsu T.

Chembiochem. 2019 Jul 1;20(13):1684-1687. doi: 10.1002/cbic.201900079. Epub 2019 May 17.

PMID:
30802345
41.

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.

Hinohara K, Wu HJ, Sébastien Vigneau, McDonald TO, Igarashi KJ, Yamamoto KN, Madsen T, Fassl A, Egri SB, Papanastasiou M, Ding L, Peluffo G, Cohen O, Kales SC, Lal-Nag M, Rai G, Maloney DJ, Jadhav A, Simeonov A, Wagle N, Brown M, Meissner A, Sicinski P, Jaffe JD, Jeselsohn R, Gimelbrant AA, Michor F, Polyak K.

Cancer Cell. 2019 Feb 11;35(2):330-332. doi: 10.1016/j.ccell.2019.01.012. No abstract available.

42.

Elucidation of secondary alcohol metabolism in Starmerella bombicola and contribution of primary alcohol oxidase FAO1.

Takahashi F, Igarashi K, Takimura Y, Yamamoto T.

FEMS Yeast Res. 2019 Mar 1;19(2). pii: foz012. doi: 10.1093/femsyr/foz012.

43.

Analyses of the possible anti-tumor effect of yokukansan.

Han C, Kawata M, Hamada Y, Kondo T, Wada J, Asano K, Makabe H, Igarashi K, Kuzumaki N, Narita M, Kobayashi H, Narita M.

J Nat Med. 2019 Jun;73(3):468-479. doi: 10.1007/s11418-019-01283-x. Epub 2019 Feb 9.

PMID:
30739283
44.

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.

BMC Musculoskelet Disord. 2019 Feb 9;20(1):68. doi: 10.1186/s12891-019-2453-z.

45.

Aberrant epigenetic gene regulation in hippocampal neurogenesis of mouse offspring following maternal exposure to 3,3'-iminodipropionitrile.

Tanaka T, Nakajima K, Masubuchi Y, Ito Y, Kikuchi S, Ideta-Ohtsuka M, Woo GH, Yoshida T, Igarashi K, Shibutani M.

J Toxicol Sci. 2019;44(2):93-105. doi: 10.2131/jts.44.93.

46.

High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer.

Hoffman RM, Murakami T, Kawaguchi K, Igarashi K, Tan Y, Li S, Han Q.

Methods Mol Biol. 2019;1866:149-161. doi: 10.1007/978-1-4939-8796-2_12.

PMID:
30725414
47.

Methioninase Cell-Cycle Trap Cancer Chemotherapy.

Hoffman RM, Yano S, Igarashi K.

Methods Mol Biol. 2019;1866:133-148. doi: 10.1007/978-1-4939-8796-2_11.

PMID:
30725413
48.

Current and Emerging Targets in Immunotherapy for Osteosarcoma.

Miwa S, Shirai T, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H.

J Oncol. 2019 Jan 1;2019:7035045. doi: 10.1155/2019/7035045. eCollection 2019. Review.

49.

Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.

Kojima K, Nakamura T, Ooizumi Y, Igarashi K, Tanaka T, Yokoi K, Ishii S, Nishizawa N, Katoh H, Kosaka Y, Sato T, Watanabe M, Yamashita K.

PLoS One. 2019 Jan 24;14(1):e0211108. doi: 10.1371/journal.pone.0211108. eCollection 2019.

50.

Dissected peripancreatic tissue margin is a critical prognostic factor and is associated with a K-ras gene mutation in pancreatic ductal adenocarcinoma.

Nishizawa N, Kumamoto Y, Katoh H, Ushiku H, Yokoi K, Tanaka T, Ishii S, Igarashi K, Tajima H, Kaizu T, Yoshida T, Saegusa M, Watanabe M, Yamashita K.

Oncol Lett. 2019 Feb;17(2):2141-2150. doi: 10.3892/ol.2018.9839. Epub 2018 Dec 17.

Supplemental Content

Loading ...
Support Center